COGNITIVE & NOOTROPIC / COLOPHON
About This Reading Desk
A citation-anchored dive log through the research on neuroactive peptides. Not a vendor. Not a clinic. Not medical advice.
What Deep Dive Peptides is
Deep Dive Peptides is a dive log through the published research on two peptides studied for cognition, focus, mood, anxiety, and sleep: Semax and Selank, with Semax as the lead compound. It sets out to make a scattered, geographically concentrated, and frequently misrepresented literature readable — to tell a curious person, plainly and with citations, what each compound was actually studied for, the species it was studied in, and how far the evidence honestly reaches.
The organizing idea is the distinction between two complementary approaches to cognitive neuroactive peptides: Semax as a neurotrophic and neuroprotective compound (BDNF, NGF, cerebral ischemia), and Selank as a non-benzodiazepine anxiolytic compound (GABA modulation, enkephalin stabilization, stress response). Reading them together gives a richer picture of what research peptides in this space actually do and do not do, than reading either one alone.
Each compound has its own page with mechanism, findings, community-reported signals, and cited safety cautions; a comparison page lines them up side by side; and a single aggregated references list collects every source cited across the desk.
How it is compiled
Three commitments govern what appears on this site.
First, everything is anchored to the peer-reviewed literature. Each research claim carries a numbered citation — PubMed-indexed journal articles and reviews, with DOIs and PubMed links — collected on the references page. Where a finding comes from a review article rather than a primary study, the review is cited as such, and we distinguish its level of evidence from primary data.
Second, the evidence is reported at its actual strength. Doses are described the way the study described them — for example, a single 50 micrograms per kilogram intranasal dose in male Wistar rats — never scaled to humans or offered as a recommendation. Where evidence is preclinical, single-lab, from a geographically narrow institutional base, or published in Russian with English abstracts only, the text says so plainly. That candor about limits is the point of the desk.
Third, community-reported effects are included but clearly labeled. For compounds like Semax and Selank that are used outside any clinical framework, the nootropics-forum and peptide-community anecdotal record is a real part of the picture — but it is labeled throughout as "anecdotal, not clinical evidence" and kept separate from what peer-reviewed studies actually established. Honest coverage of these compounds means covering both.
What it is not
Deep Dive Peptides is not a store, a clinic, or a source of medical advice. It sells and supplies nothing; it sources and brokers no peptide or research chemical; it holds no affiliate or referral arrangement with any vendor. No clinicians are on the log — it diagnoses no condition, prescribes nothing, and recommends no dose, schedule, or route for any person.
The peptides discussed here are research compounds that are not approved medicines in the US or EU. Readers with genuine health concerns should consult a licensed clinician operating in their own jurisdiction, with access to regulated, evidence-based options. The value this site offers is a careful, accurate reading of the available literature — nothing more, and nothing it pretends to be.